Other drugs Angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, ezetimibe, and proprotein convertase subtilisin / kexin type 9 (PCSK9) inhibitors have anti-inflammatory properties that reduce risk of atherosclerosis independent of their effects on blood pressure and lipid, and glucose levels.